cell
cultur
fo
mous
myeloma
cell
atcc
murin
sarcoma
cell
atcc
obtain
american
type
cultur
collect
hybridoma
mab
cell
develop
laboratori
fo
cell
hybridoma
mab
cell
produc
antibodi
felin
tnfalpha
maintain
dulbecco
modifi
eagl
minimum
essenti
medium
supplement
fc
antibiot
cell
maintain
rpmi
growth
medium
supplement
fc
antibiot
polybren
clone
variabl
region
heavi
chain
light
chain
mab
constant
region
heavi
chain
light
chain
felin
immunoglobulin
rna
isol
cell
cdna
prepar
perform
employ
method
variabl
region
gene
mab
vh
vl
amplifi
pcr
cdna
hybridoma
mab
mrna
constant
region
gene
felin
immunoglobulin
heavi
chain
ch
amplifi
cdna
felin
peripher
blood
mononuclear
cell
mrna
constant
region
gene
felin
immunoglobulin
light
chain
cl
artifici
synthes
life
technolog
carlsbad
ca
usa
base
publish
nucleotid
sequenc
genbank
insert
pmat
plasmid
primer
sequenc
use
pcr
shown
tabl
vh
vl
ch
cl
individu
clone
pcrblunt
iitopo
vector
use
zero
blunt
topo
pcr
clone
kit
life
technolog
construct
express
chimer
mab
ch
cl
gene
vh
vl
fragment
insert
pcrbluntiitopo
vector
connect
use
bam
hi
linker
prepar
chimer
h
l
chain
fig
respect
chimer
h
chain
fragment
insert
ecori
site
neo
express
vector
chimer
l
chain
fragment
insert
hindiiiecorv
site
hygro
express
vector
fo
cell
cotransfect
h
lchain
express
vector
lipofectamin
life
technolog
transfect
fo
cell
cultur
medium
contain
roch
diagnost
basel
switzerland
hygromycyn
b
roch
diagnost
acquir
stabli
express
cell
line
cell
clone
twice
employ
limit
dilut
method
purif
mous
mab
chimer
mab
mous
mab
purifi
hybridoma
mab
cultur
supernat
protein
g
sepharos
ge
healthcar
chicago
il
usa
accord
product
manual
chimer
mab
purifi
cultur
supernat
protein
sepharos
ge
healthcar
purif
buffer
mab
exchang
pb
ph
amicon
centrifug
filter
devic
nmwl
millipor
billerica
usa
concentr
purifi
mab
assay
bradford
method
western
immunoblot
assay
purifi
mous
mab
chimer
mab
incub
without
rt
min
nonreduc
condit
mab
incub
min
reduc
condit
mab
run
use
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
membran
blot
block
nonfat
dri
milk
powder
tbst
mm
trishcl
ph
nacl
hr
follow
wash
membran
incub
horseradish
peroxidas
conjug
goat
antimous
igg
hl
chain
specif
southern
biotechnolog
associ
inc
birmingham
al
usa
horseradish
peroxidas
conjug
goat
antifelin
igg
whole
molecular
mp
biomed
santa
ana
ca
usa
hr
visual
substrat
min
neutral
test
mous
mab
chimer
mab
felin
tnfalpha
use
cell
neutral
test
perform
describ
previous
briefli
cell
suspend
cellsml
dilut
medium
contain
actinomycin
sigma
aldrich
st
loui
mo
usa
preincub
hr
serial
dilut
mous
mab
chimer
mab
anti
felin
apn
mab
mab
control
mab
mix
ngml
recombin
ftnfalpha
r
system
minneapoli
mn
usa
cytotox
activ
cell
ascit
cat
fip
use
natur
felin
tnfalpha
sampl
final
concentr
cytotox
activ
cell
mixtur
incub
hr
preincub
cell
seed
volum
well
plate
fifti
microlit
mixtur
ad
well
incub
hr
solut
cell
prolifer
assay
kit
kishida
chemic
co
ltd
osaka
japan
ad
cell
return
incub
hr
absorb
formazan
produc
measur
nm
spectrophotometr
plate
reader
describ
manufactur
percent
neutral
calcul
follow
formula
neutral
od
well
contain
mab
sampl
well
contain
sampl
alon
od
well
without
mab
sampl
repeateddos
test
cat
mab
repeateddos
test
perform
refer
method
report
umehashi
et
al
purifi
mous
mab
chimer
mab
pb
control
administ
specif
pathogen
free
spf
cat
age
month
sedat
medetomidin
domitor
orion
corpor
espoo
finland
spf
cat
receiv
low
mgkg
highdos
mgkg
mab
inject
cervic
vein
time
interv
serum
collect
immedi
administr
blood
pressur
puls
measur
forearm
root
tail
mab
administr
min
administr
use
fulli
automat
electron
sphygmomanomet
pettrust
aster
electr
co
yokohama
japan
measur
perform
triplic
anim
experi
perform
accord
guidelin
anim
experi
kitasato
univers
number
approv
spf
cat
maintain
temperaturecontrol
isol
facil
chang
antimous
antibodi
mous
mab
chimer
mab
cat
serum
immulon
elisa
plate
thermo
fisher
scientif
inc
waltham
usa
coat
overnight
purifi
mous
mab
dilut
carbon
buffer
ph
wash
phosphat
buffer
salin
pb
contain
plate
block
block
buffer
contain
skim
milk
pb
min
well
plate
receiv
dilut
serum
collect
mab
treat
cat
min
incub
plate
wash
horseradish
peroxidas
conjug
goat
antifelin
igg
whole
molecular
dilut
optim
concentr
dilut
ad
well
plate
incub
min
plate
wash
well
receiv
substrat
solut
incub
min
dark
substrat
solut
prepar
dissolv
ophenylenediamin
dihydrochlorid
concentr
mgml
citric
acid
buffer
ph
ad
reaction
stop
n
solut
optic
densiti
od
nm
determin
chang
neutral
activ
mous
mab
chimer
mab
react
mous
mab
chimer
mab
cat
serum
sera
collect
mabtreat
cat
dilut
medium
dilut
sera
react
one
hour
mous
mab
chimer
mab
minimum
concentr
necessari
higher
neutral
ngml
recombin
ftnfalpha
reactant
combin
recombin
ftnfalpha
final
concentr
ngml
one
hour
later
reactant
administ
cell
level
tnfalphainduc
cytotox
measur
hr
clone
variabl
region
heavi
light
chain
mab
constant
region
heavi
light
chain
felin
immunoglobulin
vh
bp
vl
bp
gene
amplifi
cdna
deriv
hybridoma
mab
fig
ch
gene
bp
amplifi
cdna
deriv
felin
pbmc
cl
gene
bp
amplifi
use
plasmid
contain
known
cl
gene
templat
pcr
product
clone
pcrblunt
iitopo
vector
sequenc
vh
ch
gene
ligat
insert
pcdna
neo
express
vector
sequenc
fig
amino
acid
sequenc
deduc
base
sequenc
confirm
show
characterist
variabl
region
mab
constant
region
felin
immunoglobulin
heavi
chain
similarli
amino
acid
sequenc
vl
cl
gene
deduc
base
sequenc
confirm
recombin
protein
characterist
variabl
region
mab
constant
region
felin
immunoglobulin
kappa
light
chain
fig
western
immunoblot
assay
mous
mab
chimer
mab
fo
cell
harbor
express
vector
cultur
chimer
mab
cultur
supernat
collect
chimer
mab
mous
mab
individu
purifi
use
protein
protein
g
column
purifi
mab
subject
sdspage
puriti
confirm
cbb
stain
protein
band
mab
detect
sdspage
purifi
chimer
mab
western
blot
mous
mab
nonreduc
mous
mab
chimer
mab
electrophores
smearlik
band
detect
higher
fig
blot
react
antimous
igg
antibodi
band
detect
lane
appli
mous
mab
band
detect
lane
appli
chimer
mab
blot
react
antifelin
igg
antibodi
band
detect
lane
appli
chimer
mab
lane
mous
mab
reduc
mous
mab
chimer
mab
electrophores
approxim
band
visibl
fig
blot
react
antimous
igg
antibodi
band
detect
lane
appli
mous
mab
band
observ
lane
chimer
mab
react
antifelin
igg
antibodi
band
approxim
detect
lane
mous
mab
band
detect
lane
chimer
mab
neutral
activ
mab
felin
tnfalpha
mous
mab
chimer
mab
test
neutral
activ
recombin
use
cytotox
assay
system
mous
mab
chimer
mab
neutral
cytotox
activ
recombin
ftnfalpha
cell
concentrationdepend
manner
fig
similarli
neutral
activ
mous
mab
chimer
mab
endogen
ftnfalpha
contain
ascit
cat
fip
confirm
mous
mab
chimer
mab
neutral
cytotox
activ
ascit
cat
fip
cell
concentrationdepend
manner
fig
mab
control
mab
neutral
cytotox
activ
recombin
ftnfalpha
ascit
cat
fip
fig
repeateddos
test
cat
purifi
mous
mab
chimer
mab
repeatedli
administ
spf
cat
interv
blood
pressur
puls
measur
administr
tabl
bodi
temperatur
tend
decreas
administr
pb
mous
mab
chimer
mab
throughout
period
administr
signific
differ
observ
among
group
neither
differ
blood
pressur
puls
group
due
dose
frequenc
chang
antimous
antibodi
mous
mab
chimer
mab
cat
serum
serum
collect
variou
time
point
cat
treat
pb
mous
mab
chimer
mab
felin
antimous
antibodi
mabinject
cat
serum
detect
use
elisa
mous
mab
fig
felin
antimous
antibodi
detect
mabinject
cat
serum
investig
whether
neutral
antibodi
mous
chimer
mab
mab
treat
cat
serum
collect
sera
react
mous
mab
chimer
mab
chang
ftnfalpha
neutral
activ
antibodi
measur
mous
mab
react
sera
cat
treat
mgkg
mous
mab
neutral
activ
decreas
fig
react
serum
pbstreat
cat
decreas
neutral
activ
observ
chimer
mab
react
serum
cat
treat
mgkg
chimer
mab
decreas
neutral
activ
chimer
mab
observ
similarli
observ
react
serum
pbstreat
cat
fig
regard
serum
cat
treat
mgkg
chimer
mab
neutral
activ
chimer
mab
decreas
react
sera
collect
administr
thereaft
day
initi
administr
fig
fip
fatal
inflammatori
diseas
caus
fipv
treatment
fipinduc
system
inflamm
antiinflammatori
drug
steroid
investig
exist
antiinflammatori
drug
transient
improv
fip
symptom
surviv
time
qualiti
life
remain
unabl
improv
previous
report
progress
fip
prevent
inhibit
physiolog
activ
inflammatori
cytokin
tnfalpha
antiftnfalpha
mous
mab
administ
cat
fip
surviv
time
qualiti
life
improv
howev
administr
mous
mab
xenogen
anim
may
caus
advers
reaction
prepar
mousefelin
chimer
mab
chimer
mab
modifi
mous
antiftnfalpha
mab
investig
ftnfalpha
neutral
activ
addit
chang
felin
antimous
antibodi
responseinduc
abil
induc
repeat
administr
purifi
mous
mab
chimer
mab
cat
investig
chimer
mab
prepar
fusion
variabl
region
antiftnfalpha
mous
mab
felin
antibodi
constant
region
express
fo
cell
mous
mab
chimer
mab
purifi
analyz
use
western
blot
antimous
igg
antibodi
react
mous
mab
react
chimer
mab
wherea
antifelin
igg
antibodi
react
mous
mab
react
chimer
mab
confirm
antigen
chimer
mab
similar
felin
igg
neutral
ftnfalpha
purifi
chimer
mab
investig
chimer
mab
neutral
recombin
natur
ftnfalpha
similarli
mous
mab
base
find
chimer
mab
possess
ftnfalpha
neutral
activ
similar
mous
mab
maintain
characterist
felin
igg
purifi
mous
mab
chimer
mab
administ
cat
five
administr
mab
caus
anaphylact
reaction
either
group
umehashi
et
al
report
relationship
repeat
administr
mous
mab
mousefelin
chimer
mab
induct
anaphylact
reaction
sever
administr
mgkg
mous
mab
chimer
mab
caus
anaphylact
reaction
cat
wherea
mgkg
mous
mab
base
find
antibodi
dose
dose
frequenc
adopt
studi
within
rang
shown
induc
anaphylact
reaction
humanmous
chimer
mab
infliximab
repeatedli
administ
human
dose
mgkg
mous
mab
exhibit
therapeut
effect
mgkg
fip
cat
dose
use
present
studi
set
base
find
experi
confirm
whether
anaphylact
reaction
induc
highdos
repeat
administr
warrant
singl
administr
mous
mab
improv
surviv
time
qualiti
life
cat
fip
howev
singl
administr
exhibit
therapeut
effect
cat
known
singl
administr
antiftnfalpha
drug
unlik
exhibit
therapeut
effect
cat
fip
thu
sever
administr
mab
necessari
treatment
howev
sever
administr
mous
mab
may
induc
anaphylact
reaction
describ
moreov
mous
mab
xenogen
protein
cat
suggest
felin
antimous
antibodi
respons
induc
cat
treat
mous
mab
decreas
reactiv
ftnfalpha
thu
reduc
therapeut
effect
possibl
felin
antichimer
antibodi
product
similar
product
antimous
mab
antibodi
rule
due
variabl
region
chimer
mab
deriv
mous
protein
thu
induct
felin
antimous
antibodi
cat
treat
mous
chimer
mab
investig
felin
antimous
antibodi
increas
serum
ftnfalpha
neutral
effect
mab
reduc
cat
treat
mous
mab
mgkg
chimer
mab
neutral
antibodi
chimer
mab
induct
observ
cat
treat
mgkg
chimer
mab
suggest
felin
antimous
antibodi
induct
prevent
modifi
mous
mab
chimer
mab
accordingli
repeat
administr
chimer
mab
may
decreas
therapeut
effect
cat
howev
cat
receiv
mgkg
chimer
mab
administr
neutral
antibodi
chimer
mab
induc
administr
strongli
suggest
chimer
mab
also
induc
product
neutral
antibodi
chimer
mab
administ
high
dose
decreas
therapeut
effect
infliximab
due
product
neutral
antibodi
chimer
mab
similarli
report
howev
neutral
antibodi
chimer
mab
product
inhibit
concomit
administr
antiinflammatori
drug
methotrex
mtx
mtx
suppress
humor
immun
respons
thought
reduc
product
antibodi
chimer
mab
infliximab
administr
concomit
mtx
administr
chimer
mab
may
also
inhibit
product
neutral
antibodi
chimer
mab
futur
studi
necessari
investig
applic
concomit
mtx
administr
chimer
mab
cat
fip
conclus
prepar
mousefelin
chimer
mab
fuse
variabl
region
antiftnfalpha
mab
felin
antibodi
constant
region
confirm
maintain
ftnfalpha
neutral
activ
chimer
mab
administ
cat
induct
felin
antimous
antibodi
respons
decreas
compar
mous
mab
administr
result
warrant
investig
dose
dose
frequenc
chimer
mab
appropri
effect
treatment
cat
fip
